Come up with a name for your new list and we'll add to it:
IOPtima was acquired by
Chengdu Kanghong Pharmaceutical Group on November 21, 2017.
IOPtima is a developer of minimally-invasive surgical ophthalmic devices. The company's flagship product, the IOPtimate, is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser …